Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;96(5):649-56.
doi: 10.1007/s12185-012-1196-5. Epub 2012 Oct 18.

Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells

Séverine Cruet-Hennequart  1 , Áine M Prendergast, Georgina Shaw, Frank P Barry, Michael P Carty
Affiliations

Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells

Séverine Cruet-Hennequart et al. Int J Hematol. 2012 Nov.

Abstract

Anthracyclines, including doxorubicin, are widely used in the treatment of leukemia. While the effects of doxorubicin on hematopoietic cells have been characterized, less is known about the response of human mesenchymal stem cells (hMSCs) in the bone marrow stroma to anthracyclines. We characterized the effect of doxorubicin on key DNA damage responses in hMSCs, and compared doxorubicin sensitivity and DNA damage response activation between isolated hMSCs and the chronic myelogenous leukemia cell line, K562. Phosphorylation of H2AX, Chk1, and RPA2 was more strongly activated in K562 cells than in hMSCs, at equivalent doses of doxorubicin. hMSCs were relatively resistant to doxorubicin such that, following exposure to 15 μM doxorubicin, the level of cleaved caspase-3 detected by western blotting was lower in hMSCs compared to K562 cells. Flow cytometric analysis of cell cycle progression demonstrated that exposure to doxorubicin induced G2/M phase arrest in hMSCs, while 48 h after exposure, 15.6 % of cells were apoptotic, as determined from the percentage of cells having sub-G1 DNA content. We also show that the doxorubicin sensitivity of hMSCs isolated from a healthy donor was comparable to that of hMSCs isolated from a chronic lymphocytic leukemia patient. Overall, our results demonstrate that high doses of doxorubicin induce the DNA damage response in hMSCs, and that cultured hMSCs are relatively resistant to doxorubicin.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cancer Cell. 2011 Sep 13;20(3):370-83 - PubMed
    1. Mol Cell. 2005 Sep 2;19(5):607-18 - PubMed
    1. Science. 1997 Apr 4;276(5309):71-4 - PubMed
    1. Curr Opin Cell Biol. 2001 Apr;13(2):225-31 - PubMed
    1. Cancer Res. 2009 Oct 15;69(20):8200-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources